Check out your Company Bowl for anonymous work chats.
New publication! In this recent publication, our experts Ellen Sluydts, Liesbet Vervoort , and Mark Kockx contributed to understanding how polyploidy increases the likelihood of false positivity when using break apart FISH probes. The study employs IHC and FISH techniques, along with next-generation sequencing to confirm FISH translocation status via a cross-platform comparison technique with the Archer® FusionPlex® Kit.
Our new Montreal labs are taking shape! Located on the former site of the Montreal Chest Institute, Inspire Bio Innovations, the new crossroads for life sciences and precision medicine, will be hosting CellCarta’s head office.
At CellCarta, we celebrate International Day of Women and Girls in Science with our leading female experts in genomics, histopathology, proteomics, immunology, and sample logistics, who work tirelessly every day to propel precision medicine.
Step into our new Naperville facility! The site offers leading testing services in genomics and histopathology.
On 12/08/2022, Simcere Diagnostics and CellCarta Biosciences Inc. announced a strategic partnership. The two companies will collaborate on clinical research for new drug developments and innovative therapeutics to provide comprehensive CRO central laboratory services worldwide.
